‘Unsavoury’ Practices: Pharma Will Need To Be More Transparent On CME Expenses In India
Faces Audits Under Revised Rules
Executive Summary
India’s revised code for marketing practices includes US Sunshine Act-like requirements converging with tax laws and puts the spotlight on continuing medical education initiatives, where pharma will need to display funding/expenditure data on their website. The Pink Sheet talks to experts on the implications and also new requirements on brand reminders and drug samples.